Cancer Research UK is the world’s leading charity dedicated to beating cancer through research. It invests more than £300 million annually into cancer research through funding schemes, conferences, initiatives, resources, and a UK-wide network of research infrastructure across basic, translational, clinical and population research.
Together we are beating cancer
Cancer Research UK
To date Cancer Research UK’s researcher community has:
4000
Researchers
7
Nobel prize winners
20,000
Academic publication contributions
A history of supporting cancer research
Since the founding body of Cancer Research UK – Imperial Cancer Research Fund – was established in the 20th century, the overarching objective to enhance understanding of cancer has prevailed. This has provided a platform to bring cancer discoveries from the laboratory to the forefront of oncology.
One of the key elements in this direction is the formation of CancerTools.org – a first of its kind cancer focussed, global non-profit research tools biorepository.
As part of Cancer Research UK, CancerTools.org shares the charity’s mission “to prevent, control and cure cancer through our ground-breaking research“. To that end, tools accessed through CancerTools.org pay for future cancer research, via a global revenue share to the inventing institute and to Cancer Research UK.
”We’re calling on research institutions and funders around the world to work with CancerTools.org to ensure that cutting edge technologies are shared effectively and efficiently. What’s more, proceeds from the distribution of these tools will be ploughed back into research, helping to further accelerate.
Iain Foulkes, Executive Director, Research & Innovation CRUK
Cancer Research Horizons
Cancer Research Horizons is a specialist oncology drug discovery, development and commercialisation company that fast tracks scientific breakthroughs for patient benefit.
They connect researchers to Cancer Research UK’s network of 4,000 researchers and clinicians and are the gateway to Cancer Research UK’s science portfolio for pharma, biotech, and investors.
As the innovation arm of Cancer Research UK, since the early 1980s Cancer Research Horizons has:
160
New drugs taken into early clinical trials
11
New cancer drugs brought to market
